The following represents disclosure information provided by authors of this abstract. The Genitourinary Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Receipt of aggressive therapies for muscle-invasive bladder cancer: Results from the National Cancer Data Base.
Phillip J. Gray
No relevant relationships to disclose
Stacey A. Fedewa
No relevant relationships to disclose
William U. Shipley
No relevant relationships to disclose
Jason Alexander Efstathiou
No relevant relationships to disclose
Katherine S. Virgo
No relevant relationships to disclose
Anthony L. Zietman
No relevant relationships to disclose